Osteopenia Completed Phase 2 / 3 Trials for Genistein (DB01645)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00355953Vascular and Skeletal Protective Effects of Genistein in Postmenopausal WomenTreatment